Citric acid and sodium citrate combination

This classification denotes an alkalinizing agent combination drug. The first component of this drug is a carboxylic acid with the molecular formula C6H8O7.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2968PHW8QPm, and which is called citric acid. European Medicines Agency schedules citric acid monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12482MIG. The term citrate is a U.S. FDA designation. SMILES: OC(CC(=O)O)(CC(=O)O)C(=O)O. The second component of this drug is an electrolyte replacement agent and anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Q73Q2JULR. European Medicines Agency schedules Sodium citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12582MIG. Sodium citrate generally arises in the molecular formula C6H5NA3O7. The term 'sodium citrate' is a U.S. Pharmacopeial Convention designation.